AI app could catch deadly skin cancer early in rare disease patients
NCT ID NCT05843994
First seen Feb 03, 2026 · Last updated May 18, 2026 · Updated 13 times
Summary
This study is creating an artificial intelligence (AI) app that can detect a dangerous type of skin cancer called squamous cell carcinoma (SCC) from photos taken by patients or their families. The app is designed for people with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic condition that causes fragile, blistering skin and a high risk of aggressive skin cancer. By catching SCCs early, the app aims to improve treatment outcomes and give patients a convenient tool to monitor their skin at home.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMOLYSIS BULLOSA DYSTROPHICA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Dermatology, Northwestern University Feinberg School of Medicine and Lurie Children's Hospital
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.